Clinical Trial Results TV
March 25, 2012: Dr. Harry Roger Buller and Dr. Anjan K. Chakrabarti discuss: The EINSTEIN PE Study: Oral Rivaroxaban Alone for Symptomat
Dr. Harry Roger Buller and Dr. Anjan K. Chakrabarti discuss: The EINSTEIN PE Study: Oral
Rivaroxaban Alone for Symptomatic Pulmonary Embolism.

Research Support/P.I., Consultant, Scientific Advisory Board: Sanofi-aventis, Bayer
HealthCare, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Pfizer, Roche, Isis,
Thrombogenic

[ Download video ]


Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 2 total votes.

These statistics are updated nightly. The last update ran on
07-23-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted